Contribution of common genetic variants to antidepressant response

Biological Psychiatry

Volumn 73, Issue 7, 2013, Pages 679-682

  Tansey, Katherine E ^a   Guipponi, Michel ^c   Hu, Xiaolan ^f   Domenici, Enrico ^e,g   Lewis, Glyn ^b   Malafosse, Alain ^c,d   Wendland, Jens R ^e   Lewis, Cathryn M ^a   McGuffin, Peter ^a   Uher, Rudolf ^a,h  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d UNIVERSITY OF GENEVA   (Switzerland)

^e Pharma Research and Early Development   (Switzerland)

^f PFIZER INC   (United States)

^g GSK   (Italy)

^h DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Antidepressant; GCTA; genetics; GWAS; heritability; pharmacogenomics

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; NORTRIPTYLINE; PAROXETINE; REBOXETINE; SERTRALINE;

ARTICLE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY CONTROL; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; INDIVIDUALITY; PHENOTYPE; TREATMENT OUTCOME;

EID: 84875134648     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2012.10.030     Document Type: Article

References (14)

1. R.L. O'Reilly, L. Bogue, and S.M. Singh Pharmacogenetic response to antidepressants in a multicase family with affective disorder Biol Psychiatry 36 1994 467 471
2. C.M. Pare, L. Rees, and M.J. Sainsbury Differentiation of two genetically specific types of depression by the response to anti-depressants Lancet 2 1962 1340 1343
3. L. Franchini, A. Serretti, M. Gasperini, and E. Smeraldi Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees J Psychiatr Res 32 1998 255 259
4. J. Yang, S.H. Lee, M.E. Goddard, and P.M. Visscher GCTA: A tool for genome-wide complex trait analysis Am J Hum Genet 88 2011 76 82
5. S. Purcell, B. Neale, K. Todd-Brown, L. Thomas, M.A. Ferreira, and D. Bender PLINK: A tool set for whole-genome association and population-based linkage analyses Am J Hum Genet 81 2007 559 575
6. H.A. Garriock, J.B. Kraft, S.I. Shyn, E.J. Peters, J.S. Yokoyama, and G.D. Jenkins A genomewide association study of citalopram response in major depressive disorder Biol Psychiatry 67 2010 133 138
7. Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls Nature 447 2007 661 678
8. R. Uher, N. Perroud, M.Y. Ng, J. Hauser, N. Henigsberg, and W. Maier Genome-wide pharmacogenetics of antidepressant response in the GENDEP project Am J Psychiatry 167 2010 555 564
9. R. Uher, W. Maier, J. Hauser, A. Marusic, C. Schmael, and O. Mors Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression Br J Psychiatry 194 2009 252 259
10. J. Yang, B. Benyamin, B.P. McEvoy, S. Gordon, A.K. Henders, and D.R. Nyholt Common SNPs explain a large proportion of the heritability for human height Nat Genet 42 2010 565 569
11. R. Uher, P. Huezo-Diaz, N. Perroud, R. Smith, M. Rietschel, and O. Mors Genetic predictors of response to antidepressants in the GENDEP project Pharmacogenomics J 9 2009 225 233
12. S.M. Purcell, N.R. Wray, J.L. Stone, P.M. Visscher, M.C. O'Donovan, and P.F. Sullivan Common polygenic variation contributes to risk of schizophrenia and bipolar disorder Nature 460 2009 748 752
13. S.H. Lee, T.R. Decandia, S. Ripke, J. Yang, P.F. Sullivan, and M.E. Goddard Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs Nat Genet 44 2012 247 250
14. G. Davies, A. Tenesa, A. Payton, J. Yang, S.E. Harris, and D. Liewald Genome-wide association studies establish that human intelligence is highly heritable and polygenic Mol Psychiatry 16 2011 996 1005